Consistently, our results demonstrated the immune TME of EGFR‐mutated NSCLC was characterized by overexpression of PDL1 and decreased infiltration by T cells, consistent with “cold” tumors, and this might explain the poor ORR in patients with EGFR‐mutated NSCLC who receive ICIs. This evidence concerns the gene EGFR and non-small cell lung carcinoma.